MedPath

Effects of Acute Ingestion of Dark Chocolate on Endothelial Function in Hypertensive Patients

Phase 4
Completed
Conditions
Hypertension
Interventions
Dietary Supplement: Dark chocolate
Registration Number
NCT01314924
Lead Sponsor
Hospital Universitario Pedro Ernesto
Brief Summary

We aimed to identify clinical and vascular parameters of treated hypertensive patients who present beneficial effects of dark chocolate for one-week period on vascular function.

Detailed Description

Recent findings indicate an inverse relationship between cardiovascular disease and consumption of flavonoids. We aimed to identify clinical and vascular parameters of treated hypertensive patients who present beneficial effects of dark chocolate for one-week period on vascular function. Twenty-one hypertensive patients in drug therapy, both genders, aged 40-65 years, were included in a prospective study with measurement of blood pressure, brachial flow-mediated dilatation (FMD), peripheral arterial tonometry (EndoPAT) and central hemodynamic parameters by SphygmoCor. After seven days of eating dark chocolate (70% cocoa) 75g/day, the clinical and vascular evaluation were repeated. Patients were divided into two groups according to the response in FMD: responders (increase in FMD, n=12) and non-responders (no improvement in FMD, n=9).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Previous diagnosis of hypertension
  • Use of one or two antihypertensive drugs
  • Systolic blood pressure between 130 and 160 mmHg
  • Diastolic blood pressure between 85 and 100 mmHg
Exclusion Criteria
  • Secondary hypertension
  • Diabetes mellitus
  • Body mass index > 35kg/m2
  • Chronic kidney disease
  • Known coronary artery disease
  • Previous stroke

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
RespondersDark chocolatePatients who present an increase in flow-mediated dilation of brachial artery.
Non respondersDark chocolatePatients who do not present an increase in flow-mediated dilation of brachial artery.
Primary Outcome Measures
NameTimeMethod
Endothelial functionOne week

Endothelial function evaluated by peripheral arterial tonometry and by flow-mediated dilation of brachial artery

Secondary Outcome Measures
NameTimeMethod
Blood pressureOne week

Systolic and diastolic blood pressure levels evaluated by an automatic device

Central hemodynamic parametersOne week

Aortic systolic blood pressure and pulse pressure evaluated by SphygmoCor. Vascular stiffness parameters such as augmentation pressure and augmentation index will also be evaluated.

Trial Locations

Locations (1)

Hospital Universitario Pedro Ernesto

🇧🇷

Rio de Janeiro, RJ, Brazil

© Copyright 2025. All Rights Reserved by MedPath